Results 71 to 80 of about 45,501 (263)
Rare Infectious Diseases: Detection and Clinical Implications
iLABMED, EarlyView.Rare infectious diseases are infections that are uncommon, have a low incidence, and are caused by newly emerging pathogens, cross‐species or ectopic infections, or host immunodeficiencies. The detection and diagnosis of rare infections is one of the main reasons for misdiagnosis and missed diagnosis.
Xin Qian +7 more
wiley +1 more source
Metastatic colorectal cancer presenting with malignant pleural effsion - a self-experience study [PDF]
, 2017 INTRODUCTION: Colorectal cancer (CRC) advanced stage (stage IVA) is characterized by distant metastasis in one organ or in one site. The aim of this study is to present a relatively rare localization of CRC dissemination, i.e.
Novakov, Ivan
core +2 more sources
Egyptian Journal of Chest Disease and Tuberculosis, 2015 Background: Tumor markers were used in malignant pleural effusion with negative cytology. Aim of the work: The aim was to assess the value of serum and pleural levels of cyfra 21-1 (fragment of cytokeratin 19) and carcinoembryonic antigen (CEA) in the ...
Waffa S. El-Shimy +3 more
doaj +1 more source
Patient‐derived xenograft models in pan‐cancer: From bench to clinic
Interdisciplinary Medicine, EarlyView.Abstract Patient‐derived xenograft (PDX) models provide a robust preclinical platform that preserves the genetic and phenotypic heterogeneity of patient tumors while mirroring their tumor genetic characteristics, which retain malignant cells and the tumor pathological structure, making them valuable for studying tumor progression and developing ...
Jiatong Li +5 more
wiley +1 more source
Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures [PDF]
, 2008 Pleural effusion is a common diagnostic problem and a challenge to the thoracic surgeon. The analysis of serum and body fluids for tumor markers is an established diagnostic procedure.
Cortese, C +6 more
core +1 more source
Leptin In Malign Pleural Efusions: May Be A New Marker?
Ankara Üniversitesi Tıp Fakültesi Mecmuas, 2011 Objective: The pleural effusions may be caused by malignant or benign diseases. In this study, it was aimed to determine the serum and pleural leptin levels in non-malignant and malignant pleural effusions.Methods: Patients with non-malignant (n=20) and ...
Serap Duru +6 more
doaj +1 more source
Survival of Patients with Malignant Pleural Effusion: A Single Center Study [PDF]
مجله علوم پزشکی صدراMalignant pleural effusion is one of the most common complications of advanced malignancies, leading to decreased quality of life and life expectancy. With the advent of new therapies, patients with malignant pleural effusion appear to be living longer ...
Mohammad Javad Fallahi +2 more
doaj +1 more source
Interdisciplinary Medicine, EarlyView.Integrating Surface‐Enhanced Raman Scattering (SERS) with machine learning creates a powerful platform for cancer management. This approach enhances diagnostic precision through non‐invasive molecular fingerprinting and enables real‐time therapeutic monitoring. By combining SERS with machine learning, it offers a comprehensive solution for early cancer
Heng‐Zhou He +9 more
wiley +1 more source
Tumour necrosis factor, interleukin-1 and adenosine deaminase in tuberculous pleural effusion [PDF]
, 1996 Tumour necrosis factor (TNF) and interleukin-1 (IL-1) are powerful mediators with a key role in inflammation. This study was undertaken to study the presence of TNF and IL-1 in tuberculous effusion where there is marked inflammation and where examination
Christacopoulou, J. +8 more
core +1 more source
Southwest Respiratory and Critical Care Chronicles, 2018 Background: Indwelling pleural catheters (IPC) have been used increasingly in patients with recurrent pleural effusions. However, data about mortality after IPC use are limited.
Samuel Copeland +4 more
doaj +1 more source